The relationship between genetic aberrations as detected by comparative genomic hybridization and vascularization in glioblastoma xenografts

Journal of Neuro-Oncology

Volumn 51, Issue 2, 2001, Pages 121-127

  Jacobus Gilhuis, H ^a   Bernsen, Hans J J A ^a,b   Jeuken, Judith W M ^a   Wesseling, Pieter ^a   Sprenger, Sandra H E ^a   Kerstens, Harold M J ^a   Wiegant, Joop ^c   Boerman, Rudolf H ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Angiogenesis; Comparative genomic hybridization; Genetic alterations; Glioblastoma; Vascularization; Xenografts

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL HYPOXIA; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GLIOBLASTOMA; GROWTH RATE; HISTOLOGY; HUMAN; MALE; MICROVASCULARIZATION; ONCOGENE; PHENOTYPE; SOLID TUMOR; TUMOR GROWTH; TUMOR MODEL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ADULT; AGED; ANIMALS; BRAIN NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NUCLEIC ACID HYBRIDIZATION; PHENOTYPE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0343831933     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010675831154     Document Type: Article

References (30)

1. Folkman J: Tumor angiogenesis: therapeutic implications. N Eng J Med 285: 1182-1186, 1971
2. Folkman J: Clinical applications of research on angiogenesis. N Eng J Med 333: 1757-1763, 1995
3. Mahaley MS, Mettlin C, Natarajan N, Laws ER, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826-836, 1989
4. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3:255-268, 1993
5. Mastronardi L, Puzzilli F, Couldwell WT, Farah JO, Lunardi P: Tamoxifen and carboplatin combinational treatment of high-grade gliomas. J Neuro-Oncol 38: 59-68, 1998
6. Leon SP, Folkerth RD, Black MP: Microvessel density is a prognostic indicator for patients with astroglial tumors. Cancer 77: 362-372, 1996
7. Lund EL, Spang-Thomsen M, Skovgaard-Poulsen H, Kristjansen PEG: Tumor angiogenesis - a new therapeutic target in gliomas. Acta Neurol Scand 97: 52-62, 1998
8. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992
9. Shweiki D, Itin A, Soffer D, et al.: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992
10. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827, 1993
11. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996
12. Kerbel RS, Viloria-Petit A, Okada F, Rak J: Establishing a link between oncogenes and tumor angiogenesis. Mol Med 4: 286-295, 1998
13. Rak J, Filmus J, Finkenzeller G, Grugel S, Marme D, Kerbel RS: Oncogenes as inducers of tumor angiogenesis. Cancer Met Rev 14: 263-277, 1995
14. Takaki S, Kuratsu J, Mihara Y, Yamada M, Ushio Y: Endothelial cell chemotactic factor derived from human glioma cell lines. J Neurosurg 76: 822-829, 1992
15. Laterra J, Indurti RR, Goldstein GW: Regulation of in vitro glia-induced microvessel morphogenesis by urokinase. J Cell Physiol 158: 317-324, 1994
16. Louis DN, Gusella JF: A tiger behind many doors: multiple pathways to malignant glioma. Trends Genet 11: 412-415, 1995
17. Wesseling P, van der Laak AWM, Link M, Teepen H, Ruiter DJ: Quantatitive analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum Pathol 29: 352-358, 1998
18. Bernsen HJJA, Rijken PFJW, Oostendorp T, van der Kogel AJ: Vascularity and perfusion of human glioma xenografted in the athymic nude mouse. Br J Cancer 71: 721-726, 1995
19. Jeuken JWM, Sprenger SHE, Wesseling P, Bernsen HJJA, Suijkerbuijk RF, Roelofs F, Macville MVE, Gilhuis HJ, van Overbeeke JJ, Boerman RH: Genetic reflection of glioblastoma biopsy material in xenografts: Characterization of 11 glioblastoma xenograft lines by comparative genomic hybridization. J Neurosurg 92: 652-658, 2000
20. Arteel GE, Thurman RG, Yates JM, Raleigh JA: Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72: 889-895, 1995
21. Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, WeisslerMC, Fowler WC, Novotny DB, Varia MA: Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as hypoxic marker. Cancer Res 58: 3765-3768, 1998
22. Westphal JR, van't Hullenaar RGM, van der Laak JAWM, Cornelissen IMHA, Schalkwijk LJM, van Muijen GNP, Wesseling P, de Wilde PCM, Ruiter DJ, de Waal RMW: Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer 76: 561-570, 1997
23. Rijken PFJW, Bernsen HJJA, van der Kogel AJ: Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 50: 141-153, 1995
24. Jeuken JWM, Sprenger SHE, Wesseling P, MacVille MVE, von Deimling A, Teepen HLJM, van Overbeeke JJ, Boerman RH: Identification of subgroups of high grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 58: 606-612, 1999
25. Mohapatra G, Bollen AW, Kim DH, Lamborn K, Moore DH, Prados M, Feuerstein BG: Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosomes Cancer 21: 195-206, 1998
26. Schroeck E, Thiel G, Lozanova T, et al.: Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and non-random chromosomal gains and losses. Am J Pathol 144: 1203-1218, 1994
27. Gulledge CJ, Dewhirst MW: Tumour oxygenation: a matter of supply and demand. Anticancer Res 16: 741-750, 1996
28. Bentz M, Plesch A, Stilgenbauer S, Dohner H, Lichter P: Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 21: 172-175, 1998
29. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-2160, 1994
30. Jung V, Romeike BF, Henn W, Feiden W, Moringlane JR, Zang KD, Urbschat S: Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 58: 993-999, 1999